Lv2
140 积分 2024-09-13 加入
RYK is a GPNMB receptor that drives MASH
6天前
已完结
GLP ‐ 1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models
8天前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
3个月前
已完结
Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology
3个月前
已完结
Design, synthesis, and structure-activity relationship study of novel GLP-1/GIP/GCG triple receptor agonists
4个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide improved liver histology in people with MASH and fibrosis: Results from a randomized, double-blind, placebo-controlled phase 2 trial
4个月前
已完结
Adipose tissue ageing: implications for metabolic health and lifespan
5个月前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
7个月前
已完结
Semaglutide and Tirzepatide to Treat Obesity
8个月前
已完结
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
8个月前
已完结
皖公网安备34019202002308
